This study was sponsored by Janssen Research and Development; Janssen Biotech makes ustekinumab. Dr. Sandborn and his associates reported numerous ties to industry sources.
News
Anti-TNF Resistant Crohn's Disease May Respond to Ustekinumab
More IBD & Intestinal Disorders News
- Low-dose aspirin provokes no flares in patients with IBD during pregnancy
- Study: CBD provides symptom relief and improvements in gastroparesis
- Even a short course of opioids could jeopardize IBD patient health
- Advances in endoscopic therapies in inflammatory bowel disease
- Selecting therapies in moderate to severe inflammatory bowel disease: Key factors in decision making
- Advancing personalized medicine in IBD
- FDA approves mirikizumab for ulcerative colitis
- RSV more common in IBD
Question 1 of 5